RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine (Retracted article. See FEB, 2023) Article

Duxbury, MS, Ito, H, Zinner, MJ et al. (2004). RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine (Retracted article. See FEB, 2023) . ONCOGENE, 23(8), 1539-1548. 10.1038/sj.onc.1207272

cited authors

  • Duxbury, MS; Ito, H; Zinner, MJ; Ashley, SW; Whang, EE

sustainable development goals

authors

publication date

  • February 26, 2004

published in

keywords

  • Biochemistry & Molecular Biology
  • CANCER
  • CELL-LINES
  • Cell Biology
  • EXPRESSION
  • GENE AMPLIFICATION
  • Genetics & Heredity
  • HYDROXYUREA
  • Life Sciences & Biomedicine
  • MOUSE
  • NF-KAPPA-B
  • OVEREXPRESSION
  • Oncology
  • RESISTANCE
  • RNA interference
  • Science & Technology
  • TUMOR-NECROSIS-FACTOR
  • cancer
  • gemcitabine
  • pancreatic adenocarcinoma
  • ribonucleotide reductase
  • siRNA

Digital Object Identifier (DOI)

publisher

  • SPRINGERNATURE

start page

  • 1539

end page

  • 1548

volume

  • 23

issue

  • 8